Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis

United European Gastroenterology Journal

Volumn 6, Issue 8, 2018, Pages 1232-1244

  Ianiro, Gianluca ^a   Maida, Marcello ^b   Burisch, Johan ^c   Simonelli, Claudia ^a   Hold, Georgina ^d   Ventimiglia, Marco ^e   Gasbarrini, Antonio ^a   Cammarota, Giovanni ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b S Elia Hospital   (Italy)

^c HILLERØD HOSPITAL   (Denmark)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

Clostridium difficile; faecal microbiota transplantation; faecal transplant; meta analysis; systematic review

Indexed keywords

CLINDAMYCIN; ENEMA; FIDAXOMICIN; VANCOMYCIN;

ARTICLE; CAPSULE ENDOSCOPY; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DUODENUM; ENDOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTROSCOPY; HUMAN; INFUSION; JADAD SCORE; JEJUNUM ENDOSCOPY; META ANALYSIS; NICE SCORE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PUSH ENTEROSCOPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT INFECTION; SCORING SYSTEM; STOMACH INTUBATION; SYSTEMATIC REVIEW;

EID: 85048032296     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640618780762     Document Type: Article

References (36)

1. Ma GK, Brensinger CM, Wu Q, Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: A cohort study. Ann Intern Med 2017; 167: 152–158
2. Cammarota G, Masucci L, Ianiro G, Randomised clinical trial: Faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015; 41: 835–843
3. van Nood E, Vrieze A, Nieuwdorp M, Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407–415
4. Kassam Z, Lee CH, Yuan Y, Faecal microbiota transplantation for Clostridium difficile infection: Systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500–8
5. Surawicz CM, Brandt LJ, Binion DG, Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478–498
6. Debast SB, Bauer MP, Kuijper EJ, European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014; 20: 1–26
7. Cammarota G, Ianiro G, Tilg H, European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017; 66: 569–580
8. Bakken JS, Borody T, Brandt LJ, Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044–1049
9. Terveer EM, van Beurden YH, Goorhuis A, How to: Establish and run a stool bank. Clin Microbiol Infect 2017; 23: 924–930
10. Quraishi MN, Widlak M, Bhala N, Systematic review with meta-analysis: The efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther 2017; 46: 479–493
11. Lee CH, Steiner T, Petrof EO, Frozen vs fresh faecal microbiota transplantation and clinical resolution of diarrhoea in patients with recurrent Clostridium difficile infection: A randomised clinical trial. JAMA 2016; 315: 142–149
12. Fischer M, Sipe BW, Rogers NA, Faecal microbiota transplantation plus selected use of vancomycin for severe complicated Clostridium difficile infection: Description of a protocol with high success rate. Aliment Pharmacol Ther 2015; 42: 470–476
13. Moher D, Liberati A, Tetzlaff J, Preferred Reporting Systems for Systemic Reviews and Meta-Analyses: The PRISMA statement. Ann Intern Med 2009; 151: 264–269
14. National Institute for Clinical Excellence. Appendix 4. Quality assessment for Case series 2008. 2015-9-9. Available at: http://www.nice.org.uk/guidance/index.jsp?action=download&o=29075 (accessed date June 2017)
15. Hayes RB, Sackett DL, Guyatt GH, Clinical epidemiology, Philadelphia: Lippincott Williams & Wilkins, 2005, pp. 31–31
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188
17. Egger M, Davey Smith G, Schneider M, Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634
18. R Core Team (2016). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: https://www.R-project.org/ (accessed 15 July 2017)
19. Hamilton MJ, Weingarden AR, Sadowsky MJ, Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 761–767
20. Kelly CR, Ihunnah C, Fischer M, Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014; 109: 1065–1071
21. Khan MA, Sofi AA, Ahmad U, Efficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection. Can J Gastroenterol Hepatol 2014; 28: 434–438
22. Lee CH, Belanger JE, Kassam Z, The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis 2014; 33: 1425–1428
23. Costello SP, Conlon MA, Vuaran MS, Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: Clinical efficacy and bacterial viability data. Aliment Pharmacol Ther 2015; 42: 1011–1018
24. Hirsch BE, Saraiya N, Poeth K, Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis 2015; 15: 191–191
25. Hagel S, Fischer A, Ehlermann P, Fecal microbiota transplant in patients with recurrent Clostridium difficile infection. Dtsch Arztebl Int 2016; 113: 583–589
26. Mandalia A, Ward A, Tauxe W, Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile. Int J Colorectal Dis 2016; 31: 1059–1060
27. Meighani A, Hart BR, Mittal C, Predictors of fecal transplant failure. Eur J Gastroenterol Hepatol 2016; 28: 826–830
28. Millan B, Park H, Hotte N, Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent Clostridium difficile infection. Clin Infect Dis 2016; 62: 1479–1486
29. Tauxe WM, Haydek JP, Rebolledo PA, Fecal microbiota transplant for Clostridium difficile infection in older adults. Therap Adv Gastroenterol 2016; 9: 273–281
30. Youngster I, Mahabamunuge J, Systrom HK, Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection. BMC Med 2016; 14: 134–134
31. Ianiro G, Valerio L, Masucci L, Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: Results from a 3- year, single-centre cohort study. Clin Microbiol Infect 2017; 23: 337.e1–337.e3
32. Terveer EM, van Beurden YH, van Dorp S, Is the lower gastrointestinal route really preferred over the upper gastrointestinal route for fecal microbiota transfer? J Clin Gastroenterol 2016; 50: 895–895
33. Kao D, Roach B, Silva M, Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: A randomized clinical trial. JAMA 2017; 318: 1985–1993
34. Hota SS, Sales V, Tomlinson G, Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial. Clin Infect Dis 2017; 64: 265–271
35. Bafeta A, Yavchitz A, Riveros C, Methods and reporting studies assessing fecal microbiota transplantation: A systematic review. Ann Intern Med 2017; 167: 34–39
36. van Beurden YH, de Groot PF, van Nood E, Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection. United European Gastroenterol J 2017; 5: 868–879